rs201979706
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001365536.1(SCN9A):c.3056A>G(p.Lys1019Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000067 in 1,598,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K1019K) has been classified as Likely benign.
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN9A | NM_001365536.1 | c.3056A>G | p.Lys1019Arg | missense_variant | Exon 17 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN9A | ENST00000642356.2 | c.3056A>G | p.Lys1019Arg | missense_variant | Exon 17 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
| SCN9A | ENST00000303354.11 | c.3056A>G | p.Lys1019Arg | missense_variant | Exon 17 of 27 | 5 | ENSP00000304748.7 | |||
| SCN9A | ENST00000409672.5 | c.3023A>G | p.Lys1008Arg | missense_variant | Exon 17 of 27 | 5 | ENSP00000386306.1 | |||
| SCN9A | ENST00000645907.1 | c.3023A>G | p.Lys1008Arg | missense_variant | Exon 17 of 27 | ENSP00000495983.1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151774Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000294 AC: 7AN: 237722 AF XY: 0.0000233 show subpopulations
GnomAD4 exome AF: 0.0000691 AC: 100AN: 1446318Hom.: 0 Cov.: 31 AF XY: 0.0000711 AC XY: 51AN XY: 717688 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151774Hom.: 0 Cov.: 31 AF XY: 0.0000810 AC XY: 6AN XY: 74070 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.3023A>G (p.K1008R) alteration is located in exon 17 (coding exon 16) of the SCN9A gene. This alteration results from a A to G substitution at nucleotide position 3023, causing the lysine (K) at amino acid position 1008 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 1008 of the SCN9A protein (p.Lys1008Arg). This variant is present in population databases (rs201979706, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SCN9A-related conditions. ClinVar contains an entry for this variant (Variation ID: 538450). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at